Thailand Accelerates Upgrading to a Life Sciences Research Hub to Address Aging Society
The Pharmaceutical Research and Manufacturers Association (PReMA) has announced a significant partnership with the Health Systems Research Institute (HSRI) to propel Thailand beyond its role as a medical treatment center and fully transition into a regional hub for life sciences research and innovation.
The primary goal of this collaboration is to prepare for the rapidly expanding aging society in Thailand. It is projected that by the year 2033, the proportion of the elderly population in the country will increase significantly, necessitating modern medical innovations and research to help care for this demographic.
This upgrade will focus on building a robust research ecosystem to attract investment and develop new medical technologies. This will not only enhance the efficiency of disease treatment but also create long-term opportunities for all Thai people to access quality medicines and health innovations.
Furthermore, developing Thailand into a life sciences hub is considered a key strategy for driving the national economy through the comprehensive medical industry, which will help create jobs and increase Thailand's competitiveness on the global stage.
In summary, the partnership between PReMA and HSRI marks a crucial step in laying a sustainable foundation for Thailand's public health, ensuring that the country has sufficient potential to look after the quality of life of its citizens amidst future demographic shifts.